Extracellular matrix metalloproteinase inducer expression has an impact on survival in human bladder cancer

Cancer Epidemiology

Volumn 34, Issue 4, 2010, Pages 478-482

  Zhong, Wei De ^a   Chen, Qing Biao ^a   Ye, Yong Kang ^a   Han, Zhao Dong ^a   Bi, Xue Cheng ^a   Dai, Qi Shan ^a   Liang, Yu xiang ^a   Zeng, Guo Hua ^b   Wang, Yue Sheng ^a   Zhu, Gang ^d   Chen, Zhi Nan ^c   He, Hui Chan ^a  

^a GUANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^d BEIJING HOSPITAL   (China)

Author keywords

Bladder cancer; Extracellular matrix metalloproteinase inducer; Immunohistochemical analysis; Metastasis; Prognosis

Indexed keywords

BIM PROTEIN; CD147 ANTIGEN; HYALURONIC ACID; MATRIX METALLOPROTEINASE; VASCULOTROPIN; TUMOR MARKER;

ADULT; AGED; ANGIOGENESIS; ANOIKIS; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER INVASION; CANCER PATIENT; CANCER REGISTRY; CANCER RESISTANCE; CANCER STAGING; CANCER SURVIVAL; CARCINOMA IN SITU; CONTROLLED STUDY; FEMALE; FIBROBLAST; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; TUMOR CELL; BLADDER TUMOR; CASE CONTROL STUDY; CHINA; COMPARATIVE STUDY; DISEASE COURSE; ENZYME IMMUNOASSAY; EPIDEMIOLOGY; METABOLISM; MIDDLE AGED; MORTALITY; SURVIVAL RATE; TUMOR RECURRENCE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTIGENS, CD147; CARCINOMA IN SITU; CASE-CONTROL STUDIES; CHINA; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 77955087592     PISSN: 18777821     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canep.2010.04.007     Document Type: Article

References (27)

1. Weiss C., Rödel F., Wolf I., Papadopoulos T., Engehausen G.D., Schrott K.M., Sauer R., Rödel C. Combined-modality treatment and organ preservation in bladder cancer. Strahlenther Onkol 2005, 181:213-222.
2. Khaled H.M., Bahnassy A.A., Raafat A.A., Zekri A.-R.N., Madboul M.S., Mokhtar N.M. Clinical significance of altered nm23-H1, EGFR, RB and p53 expression in bilharzial bladder cancer. BMC Cancer 2009, 9:32-45.
3. Sanchez-Carbayo M., Socci N.D., Lozano J.J., Haab B.B., Cordon-Cardo C. Profiling bladder cancer using targeted antibody arrays. Am J Pathol 2006, 168:93-104.
4. Khaled H.M., Bahnassi A.A., Zekri A.R., Kassem H.A., Mokhtar N. Correlation between p53 mutations and HPV in bilharzial bladder cancer. Urol Oncol 2003, 21:334-341.
5. Tang Y., Kesavan P., Nakada M.T., Yan L. Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN. Mol Cancer Res 2004, 2:73-80.
6. Tang Y., Nakada M.T., Kesavan P. Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases. Cancer Res 2005, 65:3193-3199.
7. Marieb E.A., Zoltan-Jones A., Li R. Emmprin promotes anchorage-independent growth in human mammary carcinoma cells by stimulating hyaluronan production. Cancer Res 2004, 64:1229-1232.
8. Yang J.M., O'Neill P., Jin W. Extracellular matrix metalloproteinase inducer (CD147) confers resistance of breast cancer cells to anoikis through inhibition of Bim. J Biol Chem 2006, 281:9719-9727.
9. Zhong W.D., Han Z.D., He H.C., Bi X.C., Dai Q.S., Zhu G., et al. CD147, MMP-1, MMP-2 and MMP-9 protein expression as significant prognostic factors in human prostate cancer. Oncology 2008, 75:230-236.
10. Han ZD, Bi XC, Qin WJ, He HC, Dai QS, Zou J, et al. CD147 expression indicates unfavourable prognosis in prostate cancer. Pathol Oncol Res; in press.
11. Zhou S., Liu C., Wu S.M., Wu R.L. Expressions of CD147 and matrix metalloproteinase-2 in breast cancer and their correlations to prognosis. Ai Zheng 2005, 24:874-879.
12. Li Y., Shang P., Qian A. Inhibitory effects of antisense RNA of HAb18G/CD147 on invasion of hepatocellular carcinoma cells in vitro. World J Gastroenterol 2003, 9:2174-2177.
13. Sun J., Hemle M.E. Regulation of MMP-1 and MMP-2 production through CD147/extracellular matrix metalloproteinase inducer interactions. Cancer Res 2001, 61:2276-2281.
14. Juan S., Xiang C., Takuro K. A CD147-targeting siRNA inhibits the proliferation, invasiveness, and VEGF production of human malignant melanoma cells by down-regulating glycolysis. Cancer Lett 2009, 273:140-147.
15. Ishibashi Y., Matsumoto T., Niwa M., Suzuki Y., Omura N., Hanyu N., et al. CD147 and Matrix metalloproteinase-2 protein expression as significant prognostic factors in esophageal squamous cell carcinoma. Cancer 2004, 101:1994-2000.
16. Gromova I., Gromov P., Celis J.E. Identification of true differentially expressed mRNAs in a pair of human bladder transitional cell carcinomas using an improved differential display procedure. Electrophoresis 1999, 20:241-248.
17. Moreira J.M., Gromov P., Celis J.E. Expression of the tumor suppressor protein 14-3-3σ is down-regulated in invasive transitional cell carcinomas of the urinary bladder undergoing epithelial to mesenchymal transition. Mol Cell Proteomics 2004, 3:410-419.
18. Gromova I., Gromov P., Celis J.E. Bc10: a novel human bladder cancer-associated protein with a conserved genomic structure downregulated in invasive cancer. Int J Cancer 2004, 98:539-546.
19. Bergkvist A., Ljungqvist A., Moberger G. Classification of bladder tumours based on the cellular pattern. Preliminary report of a clinical-pathological study of 300 cases with a minimum follow-up of eight years. Acta Chir Scand 1965, 130:371-378.
20. Richter J., Wagner U., Kononen J., Fijan A., Bruderer J., Schmid U., et al. High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer. Am J Pathol 2000, 157:787-794.
21. Zheng H.C., Takahashi H., Murai Y., Cui Z.G., Nomoto K., Miwa S., et al. Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis. Br J Cancer 2006, 95:1371-1378.
22. Liang Y.X., He H.C., Han Z.D., Bi X.C., Dai Q.S., Ye Y.K., et al. CD147 and VEGF expression in advanced renal cell carcinoma and their prognostic value. Cancer Invest 2009, 27:788-793.
23. Han Z.-D., Bi X.-C., Qin W.-J., He H.-C., Dai Q.-S., Zou J., et al. Expression and clinical significance of CD147 in genitourinary carcinomas. J Surg Res 2009, 1-8.
24. Riethdorf S., Reimers N., Assmann V., Kornfeld J.W., Terracciano L., Sauter G., et al. High incidence of EMMPRIN expression in human tumors. Int J Cancer 2006, 119:1800-1810.
25. Ju X.-Z., Yang J.-M., Zhou X.-Y., Li Z.-T., Wu X.-H. EMMPRIN expression as a prognostic factor in radiotherapy of cervical cancer. Clin Cancer Res 2008, 14:494-502.
26. Yu W., Liu J., Xiong X., AiYou S., Wang H. Expression of MMP9 and CD147 in invasive squamous cell carcinoma of the uterine cervix and their implication. Pathology Res Pract 2009, 205:709-715.
27. Als A.B., Dyrskjøt L., von der Maase H., Koed K., Mansilla F., Toldbod H.E., et al. Emmprin and survivin predict response and survival following cisplatin-containing chemotherapy in patients with advanced bladder cancer. Clin Cancer Res 2007, 13:4407-4414.